BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maglie R, Genovese G, Solimani F, Guglielmo A, Pileri A, Portelli F, Hertl M, Marzano AV, Antiga E. Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review. Am J Clin Dermatol 2020;21:833-54. [PMID: 32813229 DOI: 10.1007/s40257-020-00553-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Souza PKD, Amorim RO, Sousa LS, Batista MD. Dermatological manifestations of hematologic neoplasms. Part I: secondary specific skin lesions. Anais Brasileiros de Dermatologia 2022. [DOI: 10.1016/j.abd.2022.06.002] [Reference Citation Analysis]
2 Doshi S, Lee Y. Pyoderma Gangrenosum Mimicking Necrotizing Fasciitis in a Marathon Runner With Myelodysplastic Syndrome. AIM Clinical Cases 2022;1. [DOI: 10.7326/aimcc.2022.0240] [Reference Citation Analysis]
3 Quintarelli L, Coi A, Maglie R, Corrà A, Mariotti EB, Aimo C, Ruffo di Calabria V, Verdelli A, Bianchi B, Del Bianco E, Antiga E, Caproni M. Clinical Patterns, Survival, Comorbidities, and Treatment Regimens in 149 Patients With Pemphigus in Tuscany (Italy): A 12-Year Hospital-Based Study. Front Immunol 2022;13:895490. [DOI: 10.3389/fimmu.2022.895490] [Reference Citation Analysis]
4 André F, Prins C, Gillet M, Guenova E, Blanchard G. CD30+ Transformed Mycosis Fungoides Associated with Sweet-like Dermatosis. Acta Derm Venereol 2022;102:adv00739. [DOI: 10.2340/actadv.v102.1170] [Reference Citation Analysis]
5 Kar BR, Agarwal A. Haematologic-Related Malignancy-Induced Eosinophilic Dermatoses (He Remained): A Narrative Review. Indian J Dermatol 2022;67:206. [PMID: 36092203 DOI: 10.4103/ijd.ijd_847_21] [Reference Citation Analysis]
6 Alvarez-Payares JC, Molina A, Gallo S, Ramirez J, Hernandez J, Lopez F, Ramirez-Urrea SI, Álvarez C. Immune-Mediated Cutaneous Paraneoplastic Syndromes Associated With Hematologic Malignancies: Skin as a Mirror of Hematologic Neoplasms. Cureus 2021;13:e19538. [PMID: 34934556 DOI: 10.7759/cureus.19538] [Reference Citation Analysis]
7 Hudemann C, Maglie R, Llamazares M, Beckert B, Didona D, Tikkanen R, Schmitt T, Hashimoto T, Waschke J, Hertl M, Eming R. Human desmocollin 3-specific IgG antibodies are pathogenic in a humanized HLA-class II transgenic mouse model of pemphigus. J Invest Dermatol 2021:S0022-202X(21)01440-8. [PMID: 34265330 DOI: 10.1016/j.jid.2021.06.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Hines A, Hazim A, Wetter DA, Bridges AG, Camilleri MJ, McEvoy MT, El-Azhary RA, Davis MDP, Sartori-Valinotti JC. Retrospective analysis of 578 inpatient dermatology consultations in hematology and hematopoietic stem cell transplant patients. Int J Dermatol 2021. [PMID: 33991106 DOI: 10.1111/ijd.15650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Maglie R, Ugolini F, De Logu F, Simi S, Senatore S, Montefusco F, Nassini R, Massi D, Antiga E. Dupilumab for the treatment of recalcitrant eosinophilic dermatosis of haematologic malignancy. J Eur Acad Dermatol Venereol 2021;35. [DOI: 10.1111/jdv.17232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
10 Maglie R, Montefusco F, Senatore S, D'Erme AM, Bagnoni G, Antiga E. Localized pemphigus exacerbation associated with underlying breast cancer. JAAD Case Rep 2020;6:1268-70. [PMID: 33294561 DOI: 10.1016/j.jdcr.2020.10.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Solimani F, Meier K, Zimmer CL, Hashimoto T. Immune serological diagnosis of pemphigus. Ital J Dermatol Venerol 2021;156:151-60. [PMID: 33228340 DOI: 10.23736/S2784-8671.20.06788-7] [Reference Citation Analysis]